Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles.
Statistics Core, Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles.
JAMA Netw Open. 2024 Oct 1;7(10):e2437148. doi: 10.1001/jamanetworkopen.2024.37148.
Elevated ambient fine particulate matter (PM2.5) air pollution exposure has been associated with poor health outcomes across several domains, but its associated outcomes among lung transplant recipients are poorly understood.
To investigate whether greater PM2.5 exposure at the zip code of residence is associated with a higher hazard for mortality and graft failure in patients with lung transplants.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used panel data provided by the United Network for Organ Sharing, which includes patients receiving transplants across all active US lung transplant programs. Adult patients who received lung transplants between May 2005 and December 2016 were included, with a last follow-up of September 10, 2020. Data were analyzed from September 2022 to May 2023.
Zip code-level annual PM2.5 exposure was constructed using previously published North American estimates.
The primary outcome was time to death or lung allograft failure after lung transplant. A gamma shared frailty Cox proportional hazards model was used to produce unadjusted and adjusted hazard ratios (HRs) to estimate the association of zip code PM2.5 exposure at the time of transplant with graft failure or mortality.
Among 18 265 lung transplant recipients (mean [SD] age, 55.3 [13.2] years; 7328 female [40.2%]), the resident zip code's annual PM2.5 exposure level was greater than or equal to the Environmental Protection Agency (EPA) standard of 12μg/m3 for 1790 patients (9.8%) and less than the standard for 16 475 patients (90.2%). In unadjusted analysis, median graft survival was 4.87 years (95% CI, 4.57-5.23 years) for recipients living in high PM2.5 areas and 5.84 years (95% CI, 5.71-5.96 years) for recipients in the low PM2.5 group. Having an annual PM2.5 exposure level greater than or equal to the EPA standard 12 μg/m3 was associated with an increase in the hazard of death or graft failure (HR, 1.11; 95% CI, 1.05-1.18; P < .001) in the unadjusted analysis and after adjusting for covariates (HR, 1.08; 95% CI, 1.01-1.15; P = .02). Each 1 μg/m3 increase in exposure was associated with an increase in the hazard of death or graft failure (adjusted HR, 1.01; 95% CI, 1.00-1.02; P = .004) when treating PM2.5 exposure as a continuous variable.
In this study, elevated zip code-level ambient PM2.5 exposure was associated with an increased hazard of death or graft failure in lung transplant recipients. Further study is needed to better understand this association, which may help guide risk modification strategies at individual and population levels.
环境细颗粒物(PM2.5)空气污染暴露水平升高与多个领域的健康结果不佳有关,但在肺移植受者中的相关结果尚不清楚。
研究居住邮政编码处的 PM2.5 暴露水平升高是否与肺移植受者的死亡率和移植物失败风险增加相关。
设计、地点和参与者:本回顾性队列研究使用了美国器官共享联合网络提供的面板数据,其中包括所有美国活跃肺移植项目中的移植受者。纳入了 2005 年 5 月至 2016 年 12 月期间接受肺移植的成年患者,最后随访时间为 2020 年 9 月 10 日。数据分析于 2022 年 9 月至 2023 年 5 月进行。
使用先前发表的北美的估计值构建了邮政编码水平的年度 PM2.5 暴露。
主要结局是肺移植后死亡或移植物失败的时间。使用伽马共享脆弱性 Cox 比例风险模型产生未经调整和调整后的风险比(HR),以估计移植时邮政编码 PM2.5 暴露与移植物失败或死亡率之间的关联。
在 18265 名肺移植受者中(平均[标准差]年龄为 55.3[13.2]岁;7328 名女性[40.2%]),1790 名患者(9.8%)的居民邮政编码的年 PM2.5 暴露水平大于或等于环境保护署(EPA)12μg/m3 的标准,而 16475 名患者(90.2%)的暴露水平低于标准。在未经调整的分析中,居住在 PM2.5 水平较高地区的受者中位移植物存活率为 4.87 年(95%CI,4.57-5.23 年),而居住在 PM2.5 水平较低地区的受者中位移植物存活率为 5.84 年(95%CI,5.71-5.96 年)。每年 PM2.5 暴露水平大于或等于 EPA 标准 12μg/m3 与死亡或移植物失败风险增加相关(HR,1.11;95%CI,1.05-1.18;P<0.001),且在调整协变量后仍如此(HR,1.08;95%CI,1.01-1.15;P=0.02)。PM2.5 暴露每增加 1μg/m3,与死亡或移植物失败风险增加相关(调整 HR,1.01;95%CI,1.00-1.02;P=0.004),当将 PM2.5 暴露视为连续变量时。
在这项研究中,邮政编码水平环境 PM2.5 暴露升高与肺移植受者的死亡或移植物失败风险增加相关。需要进一步研究以更好地了解这种关联,这可能有助于指导个体和人群层面的风险修正策略。